Crown Bioscience Becomes Ninth Member of C-Path New Approach Methodologies Developer Coalition

Crown Bioscience has joined the Critical Path Institute’s (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC) as its ninth member. This partnership aims to advance the validation, qualification, and adoption of new approach methodologies (NAMs) to improve the drug discovery and development process.

The coalition coordinates a precompetitive effort among industry developers to standardize these methodologies. Crown Bioscience joins a group that currently includes CN Bio, Curi Bio, and Emulate. By integrating these organizations, the coalition seeks to establish a framework for how these new scientific approaches function within the broader pharmaceutical research landscape.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: July 16, 2026

Author

GOAI